- Home
- Labeler Index
- Sanofi-aventis U.s. Llc
- 0024-5869
- NDC Crossover: 0024-5869 Toujeo
NDC Crossover 0024-5869 Toujeo
View and Compare Similar Products, Alternatives & Options
NDC Crossover of Similar Products Matching Insulin Glargine
The Similar Products in this help users find alternative medications and related products based on key similarities in their regulatory status, product name, active ingredients, dosage form, and administration route.
Explore similar products to 0024-5869 – Toujeo, a human prescription drug. This list includes other cross-matching products that share:
- The same product name: Toujeo
- OR Generic name: Insulin Glargine
- AND the same Administration Route: subcutaneous
- OR Dosage Form: injection, solution
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
---|---|---|---|---|---|---|
0024-5871 | Toujeo Max | Insulin Glargine | Injection, Solution | Subcutaneous | Sanofi-aventis U.s. Llc | Human Prescription Drug |
0955-2900 | Insulin Glargine U-300 Max | Insulin Glargine | Injection, Solution | Subcutaneous | Sanofi-aventis U.s. Llc | Human Prescription Drug |
0955-3900 | Insulin Glargine U-300 | Insulin Glargine | Injection, Solution | Subcutaneous | Sanofi-aventis U.s. Llc | Human Prescription Drug |
50090-2193 | Toujeo | Insulin Glargine | Injection, Solution | Subcutaneous | A-s Medication Solutions | Human Prescription Drug |
50090-4177 | Toujeo Max | Insulin Glargine | Injection, Solution | Subcutaneous | A-s Medication Solutions | Human Prescription Drug |